Drug intelligence / Profile preview

omega-3 fatty acids (Menoufia University)

Development stage
Unknown
Lead developer
Menoufia University
Modality
Small Molecules
Administration
Oral
01

Overview

Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are long-chain polyunsaturated fatty acids typically derived from fish oil. In the context of sepsis, they are utilized for their potent immunomodulatory and anti-inflammatory properties. These fatty acids function by competitively inhibiting the metabolism of arachidonic acid through the cyclooxygenase (COX) and lipoxygenase (LOX) pathways, thereby reducing the production of pro-inflammatory eicosanoids. Furthermore, they serve as precursors for specialized pro-resolving mediators (SPMs), such as resolvins and protectins, which actively promote the resolution of inflammation. Menoufia University conducted a randomized clinical trial (NCT04121520) to evaluate the efficacy of enteral omega-3 supplementation in reducing organ dysfunction, as measured by SOFA scores, and modulating inflammatory markers in critically ill septic patients.

Other names
fish oiln-3 polyunsaturated fatty acidsn3 polyunsaturated fatty acidsn 3 polyunsaturated fatty acidsn-3 PUFAn3 PUFAn 3 PUFAeicosapentaenoic aciddocosahexaenoic acidEPADHA
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PPARG (Peroxisome proliferator-activated receptor gamma)ALOX5 (Arachidonate 5-lipoxygenase)FFAR4 (Free fatty acid receptor 4)

Beyond the preview

Go deeper on omega-3 fatty acids (Menoufia University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3 fatty acids (Menoufia University).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call